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Diﬃculty with emotion recognition is increasingly being recognized as a symptom of Parkinson’s disease. Most research into this
area contends that progressive cognitive decline accompanying the disease is to be blamed. However, facial mimicry (i.e., the
involuntary congruent activation of facial expression muscles upon viewing a particular facial expression) might also play a role
and has been relatively understudied in this clinical population. In healthy participants, facial mimicry has been shown to improve
recognition of observed emotions, a phenomenon described by embodied simulation theory. Due to motor disturbances,
Parkinson’s disease patients frequently show reduced emotional expressiveness, which translates into reduced mimicry. Therefore,
it is likely that facial mimicry problems in Parkinson’s disease contribute at least partly to the emotional recognition deﬁcits that
these patients experience and might greatly inﬂuence their social cognition abilities and quality of life. The present review aims to
highlight the need for further inquiry into the motor mechanisms behind emotional recognition in Parkinson’s disease by
synthesizing behavioural, physiological, and neuroanatomical evidence.

1. Introduction
Parkinson’s disease (PD) is a neurodegenerative illness
arising due to the loss of dopamine-producing neurons in
the substantia nigra pars compacta (SNc) [1, 2]. The loss of
these neurons leads to a reduction in dopamine neurotransmission in the basal ganglia, resulting in overinhibition
of certain motor and cognitive pathways [3]. The basal
ganglia are subcortical nuclei comprising the striatum,
globus pallidus, substantia nigra, and subthalamic nucleus
[4, 5]. Common motor symptoms include reduced number
and amplitude of movements (i.e., hypokinesia), slowed
movement (i.e., bradykinesia), rigidity, tremor, and instability, whereas cognitive symptoms include impaired
working memory, attention, and cognitive ﬂexibility [1–3].
Emotional processing impairments are increasingly acknowledged by clinicians and researchers as another common symptom of PD [6, 7].
Recent reviews on emotion processing in PD patients
have highlighted that patients display a global reduction in

emotion recognition abilities, with speciﬁc deﬁcits for
negative emotions such as disgust [6–9]. However, deﬁcits
have been found for all six basic emotions (happiness,
surprise, anger, sadness, fear, and disgust) across a number
of studies [10–12]. This impairment has been shown to be
independent of general deﬁcits in face processing [13],
emotion regulation abilities [14, 15], problems with lowerorder vision [16], and cognitive function [17]. However,
there appears to be a large degree of inconsistency within the
literature, as there are several factors that make it diﬃcult to
compare results across studies (e.g., medication status,
length/stage of illness, and depression). Consequently, it is
diﬃcult to determine the cause or contributing factors behind emotion recognition deﬁcits.
Another common observation in PD is reduced emotional expressivity, which has been demonstrated for both
spontaneous and voluntary displays of emotion. This is
thought to arise due to dopamine depletion in the basal
ganglia leading to hypokinesia and bradykinesia of the facial
muscles [18]. Interestingly, some studies have shown there
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exists a relationship between reductions in emotional expressivity and emotion recognition [8, 10, 15].
This link between emotional recognition and expressivity might be explained by an important mirroring behaviour. Facial mimicry describes the unconscious
mirroring of others’ emotional facial expressions by activating one’s own congruent facial muscles [19]. Embodied
simulation theory suggests that facial mimicry aids in the
recognition and understanding of others’ emotions through
an emotional feedback mechanism. Once an expression is
mimicked, the brain associates the accompanying sensorimotor feedback signals with a certain emotion, which is then
experienced on some level by the observer and recognized
[20, 21]. Indeed, healthy participants have shown reductions
in emotion recognition abilities when facial mimicry is
blocked [22–24]. Neuroimaging research has also elucidated
areas of the brain that are highly active during facial
mimicry, particularly in areas of the basal ganglia
(e.g., caudate nucleus) and of the mirror neuron system
(e.g., inferior frontal operculum) [25, 26].
Given that emotional expressivity [15, 27], basal ganglia
function [28], and mirror neuron system activity [29] are all
reduced in PD patients, it is likely that facial mimicry is also
reduced. However, there are currently only two studies that
have investigated facial mimicry in PD patients [30, 31].
Based on the demonstrated link between facial mimicry and
emotional recognition, it seems likely that PD patients’
reductions in facial mimicry contribute at least somewhat to
their impairment in emotion recognition. The present review therefore aims to summarize evidence surrounding
emotional recognition and expressivity in PD patients, facial
mimicry in healthy participants and PD patients, and the
neural correlates of facial mimicry and emotion recognition.
The overarching aim of this review is to underline the need
for further inquiry in the area of facial mimicry in PD
patients. We predict that facial mimicry is an important,
relatively unexplored contributing factor to emotion recognition impairments in PD patients.

2. Emotion Recognition in PD
Recent reviews on emotion recognition in PD patients have
highlighted a large degree of inconsistency within the literature on this topic. While most reviews agree that emotion
recognition deﬁcits are found in the majority of studies,
there are many contradictions and incidental ﬁndings.
According to Assogna et al. [7], disgust is the facial expression which is least recognized by patients with PD. For
example, using an assessment which controlled task diﬃculty, Suzuki et al. [32] identiﬁed a speciﬁc impairment for
disgust recognition in dopamine-medicated PD patients
compared to controls. Interestingly, this result was corroborated by Sprengelmeyer and colleagues [33], but only
for PD patients oﬀ medication; those that were on medication failed to show any diﬀerence in the recognition of
disgust compared to controls.
In their review, Argaud et al. [6] reported that 64% of
relevant studies found a global reduction in the recognition
of the six basic emotions. However, the authors also
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highlight a multitude of factors which may confound results,
including a lack of stimuli continuity, varying levels of task
diﬃculty, and failure to control for dopaminergic therapy.
For example, static facial expression photographs are widely
used as stimuli in emotion recognition research, but dynamic video stimuli tend to be more ecologically valid [34].
Argaud and colleagues explain that the use of static stimuli
might artiﬁcially inﬂate the emotion recognition deﬁcit in
PD patients, as dynamic emotional stimuli have indeed been
found to be more easily recognized by PD patients [6, 35].
In their meta-analysis, Gray and Tickle-Degnen [8] also
observed a general deﬁcit in emotion recognition for PD
patients compared to healthy controls. In addition, they
suggest that the recognition of negative emotions is more
impaired than that of positive emotions. Indeed, Lawrence
et al. [36] found that PD patients oﬀ of their normal dopamine therapy regime had diﬃculty recognizing anger.
However, Aiello and colleagues [37] also tested patients oﬀ
medication and found no diﬀerence from controls in anger
recognition (or for any emotions, for that matter). Taken
together, these reviews demonstrate that emotion recognition abilities do seem to be reduced in PD patients but that
the literature is not entirely clear on how or why. As a ﬁnal
note, many studies investigating emotion recognition in PD
patients controlled for potential confounding factors such as
bradykinesia which would slow response times [13, 38] and
depression [39].

3. Facial Expressiveness in PD Patients
Facial hypomimia, or “masking” of facial expression, is
a symptom of PD arising from bilateral hypokinesia and
bradykinesia of the muscles of facial expression [18]. As
a result, PD patients are less able to produce emotional
expressions and can appear “cold” or unhappy to others.
Spontaneous emotional expressions seem to be particularly
aﬀected by PD, as these are mediated by a habitual control
loop between the basal ganglia and the cortex which is
especially damaged by the disease [18,40–43]. For example,
Simons et al. [44] made PD patients and healthy controls
watch amusing videos designed to elicit spontaneous expressions. During the videos, PD patients were signiﬁcantly
less expressive than controls. This was not due to a decreased
ability to feel emotions, as both PD patients and controls
indicated a similar level of self-reported amusement during
these videos. Similarly, Ricciardi et al. [15] documented
reduced emotional expressivity in PD patients compared to
controls who were asked to describe a typical day.
Simons and colleagues [27] cleverly investigated the
interplay between spontaneous and voluntary facial expression in PD patients by having participants pose incongruent expressions while smelling certain odours
(e.g., posing a smile during a foul odour). Compared to
controls, PD patients demonstrated a reduced ability to
mask their negative expressions with a positive one, with
many patients showing blending of both positive and
negative expressions. This result intriguingly suggests that
deﬁcits in facial expression might not simply result from
hypokinesia and bradykinesia leading to general facial
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muscular control problems. Simons et al.’s [27] ﬁndings are
analogous to the cognitive control deﬁcits that occur in PD
patients. It is well documented that PD patients have difﬁculty averting attention from more naturally salient to less
salient stimuli or overriding more automatic or innate responses when they are incongruous with requested but less
habitual responses [45–50]. In this way, subtle cognitive
changes associated with PD could also contribute to facial
expression deﬁcits.
3.1. Relationship between Emotion Recognition and Emotional
Expression in PD Patients. Deﬁcits in emotion recognition
and expression for PD patients seem to be related, as evidenced by correlations in several studies. For example,
Ricciardi and colleagues [10] made participants to complete
the Ekman 60 Faces test (a test of emotional recognition) and
imitate the expressions that were displayed. Compared to
controls, PD patients performed worse at recognizing all of
the six basic emotions (except for disgust) and were judged
to be less expressive for happiness, anger, and sadness, which
was accompanied by a correlation of r � 0.48 between the
ability to express and recognize the six basic emotions. In
fact, an even greater correlation was found when the
emotions were ranked from best to least recognized (r �
0.75). Similarly, in their meta-analysis, Gray and TickleDengen [8] report that the average correlation between
recognition and expressivity across a number of studies was r
� 0.47. It is important to note that not all studies have
demonstrated this link, however. Although Bologna and
colleagues [51] found deﬁcits in emotional expressivity and
emotional recognition in PD patients, there was no correlation between these two deﬁcits. Correlation does not imply
causation, making these studies in PD patients diﬃcult to
interpret. There is evidence in healthy populations; however,
that interfering with emotional expression reduces emotion
recognition as will be detailed in the sections below.

4. Facial Mimicry
Facial mimicry is a nonconscious, involuntary behaviour
involving congruent activation of facial muscles upon observing another’s expression [19]. For example, when observing a happy face, one tends to activate the zygomaticus
major muscles, which turn the corners of the mouth upwards into a smile, as well as the orbicularis oculi muscles,
which are responsible for squinting the eyes. Similarly, when
observing an angry face, one tends to activate the corrugator
supercilii muscles, which furrow the brow [19]. This behaviour occurs very quickly (within 300–400 msec) and is
present from infancy [52, 53].
Research on facial mimicry has shown that it might be
related to processing the information conveyed by others’
emotions. As mentioned previously, the relation between
emotion recognition and expressiveness in PD patients has
been documented a number of times [8, 10, 15]. Similar
correlations in healthy participants have been shown by
Künecke et al. [54], during a psychometric study in which
participants had to choose which of the six basic emotions
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was shown in a video while having facial muscle activity
measured through electromyography (EMG). Participants
who demonstrated less EMG activity during the task also
demonstrated worse emotion recognition, with a correlation
coeﬃcient of r � 0.32 between corrugator supercilii mimicry
activity and anger recognition.
4.1. Embodied Simulation Theory. Embodied simulation
theory suggests that facial mimicry aids in the recognition of
emotions through a sensorimotor feedback loop [20, 21].
This theory is primarily supported by research investigating
the consequences of blocking facial muscles during the
observation of facial emotions. Oberman et al. [22] prevented participants from engaging in facial mimicry by
having them either chew gum or bite a pen while engaging in
an emotion recognition task. The pen-biters performed
signiﬁcantly worse at recognizing happiness than gumchewers or control participants, presumably because the
zygomaticus major muscles were tonically engaged. A
similar methodology was employed by Ponari et al. [23],
who used chopstick biting to demonstrate reductions in
happiness and disgust recognition. These authors also used
an eyebrow sticker-touching task to demonstrate reduction
in anger recognition.
Chemical interference with muscular activation has also
shown to impede emotion recognition. Neal and Chartrand
[55] tested individuals with either botulinum toxin (Botox;
which prevents muscle contraction) or dermal ﬁller
(Restylane; which leaves muscle activity intact) injections on
the Reading the Mind in the Eyes task. This task presents
participants with photographs of the eye region of the face
during a particular expression and asks them to indicate the
emotion expressed through the eyes. The Botox group
performed worse at recognizing positive and negative expressions, regardless of response time. Importantly, these
injections had been placed along the glabella (between
eyebrows), forehead, and crow’s feet (lateral sides of eyes),
which reduced the ability to use surrounding facial muscles
which are highly involved in emotional expression
(e.g., corrugator supercilii and orbicularis oculi). Similarly,
a study conducted by Hennenlotter et al. [56] established
that interference with the corrugator supercilii muscles via
Botox injection reduces brain activity in the left amygdala
during imitation of angry facial expressions. Therefore, the
amygdala might rely on facial feedback to process emotions
(particularly anger). Overall, the results of these studies
suggest that a reduction in the ability to express emotions
creates changes in behaviour and brain activity related to
emotional processing. For PD patients, deﬁcits in emotional
recognition could relate to the previously established reduction in expressiveness.
4.2. Neural Correlates of Facial Mimicry. A handful of studies
have provided evidence that facial mimicry processes implicate areas of the brain which are aﬀected by PD, including
the basal ganglia and the mirroring system. Likowski et al.
[25] made participants to passively view a series of stimuli
depicting happy, sad, and angry expressions. Meanwhile, the
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activity of the zygomaticus major and corrugator supercilii
muscles was recorded using EMG, and brain activity was
recorded with fMRI. A regression analysis revealed that
increased zygomaticus activity during happy faces correlated
with activity in the caudate, an area of the basal ganglia that
has been consistently associated with emotional activation
[57, 58]. The caudate nucleus is implicated in reinforcement
of goal-directed actions [59] hinting at the possibility that
caudate’s role in facial mimicry could be to mitigate the
rewarding outcome of accurate emotion recognition. Furthermore, other research has found that an increase in
mutual trust, but not distrust, during a social exchange
activates the caudate, suggesting that this area of the basal
ganglia is particularly involved in positive social encounters
[60]. To corroborate this, Sims et al. [61] demonstrated that
healthy participants mimic happy faces, but not angry faces,
to a greater degree when the faces were previously conditioned to indicate a greater reward.
Rymarczyk et al. [26] corroborated Likowski et al.’s [25]
results by demonstrating that the caudate was activated
during facial mimicry of happy expressions but introduced
the new ﬁnding that it might also mediate processing of
angry expressions. Although caudate activity was not related
to anger in Likowski et al.’s ﬁndings, this area has indeed
been related to anger recognition [62] and avoidance behaviour [63]. In PD, the caudate receives fewer dopaminergic signals from the substantia nigra compared to
controls and even has been shown to undergo morphological
changes such as atrophy [64] and an altered shape [65].
Therefore, reduction of caudate activity in PD might underlie impairment of mimicry and/or its rewarding eﬀects,
producing deﬁcits in emotion recognition.
Rymarczyk et al. [26] also revealed coactivation between
the zygomaticus major and orbicularis oculi muscles during
happy expressions and activity in the putamen, nucleus
accumbens, and the globus pallidus, demonstrating that
areas other than the caudate within the basal ganglia system
are related to facial mimicry. These areas are often associated
with feelings of positive aﬀect (e.g., nucleus accumbens) [66]
and have been shown to be active during expressions of
happiness (e.g., putamen) [67]. Both of these areas are also
impacted by PD and dopaminergic treatment [59, 68].
Upon viewing another individual’s actions, the mirror
neuron system in humans activates areas in the observer’s
brain that are associated with performing that action [69].
Neuroanatomically, it involves the inferior frontal operculum (IFO) and the inferior parietal lobule (IPL) [29,69–71].
Since facial mimicry is a mirroring behaviour, it is not
surprising that these areas have been shown to be active
during facial mimicry, particularly for happiness
[25, 26, 72, 73]. Furthermore, Pohl et al. [29] demonstrated
that these areas might be impacted by PD. PD patients and
healthy controls completed the Emotion Hexagon task,
which involves determining which proportion of particular
emotions are shown in a photo. Brain activity was recorded
with fMRI during this task. The authors demonstrated that
controls had greater activity in the dorsal portion of the IFO
and in the IPL compared to patients. Furthermore, for PD
patients, activity in the IPL correlated with emotion
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recognition ability which corroborates the idea that mimicry
and recognition are closely linked. The authors contend that
reduced facial expressiveness due to motor disturbances as
well as reduced activity in the IFO/IPL results in emotion
recognition impairment for PD patients [29].
4.3. Facial Mimicry in Parkinson’s Disease. The evidence
reviewed so far has suggested that the impairments in
emotional expressivity and recognition in PD patients might
be linked by a reduction in facial mimicry. Neuroimaging
studies seem to suggest that the areas involved in facial
mimicry are commonly aﬀected in PD. The notion that facial
mimicry deﬁcits contribute in some way to emotion recognition impairment in PD seems plausible. Surprisingly,
there are currently only two studies investigating facial
mimicry in PD patients [30, 31].
Livingstone et al. [31] recruited healthy controls and
patients with mild-moderate PD (mean Hoehn and Yahr
stage � 2.3) who were nondepressed, nondemented, and
currently taking dopaminergic replacement therapy. The
patients were tested while taking their usual dosage of
prescribed medication. Both patients and controls had facial
EMG activity of the left zygomaticus major, left corrugator
supercilii, and right medial frontalis, recorded while being
tested on a forced-choice emotion recognition task. The task
used video stimuli of male and female actors depicting
a particular facial expression while speaking or singing
emotionally neutral phrases, and participants were asked to
indicate whether the actor was calm, happy, sad, angry,
fearful, surprised, disgusted, or neutral. Throughout the task,
PD patients demonstrated greatly reduced mimicry to happy
faces in the zygomaticus major muscles and to sad faces in
the medial frontalis compared to controls. These eﬀects were
negatively correlated with behavioural response times. In
other words, patients who displayed greater mimicry of
emotions had shorter response times when identifying the
emotional stimulus. Interestingly, although the mimicry
response to anger in the corrugator supercilii muscles was
slightly attenuated in PD patients compared to controls,
there was no statistically signiﬁcant diﬀerence between the
groups for this particular emotion. Taken together, the results from Livingstone et al. [31] seem to suggest that there is
a speciﬁc impairment in the mimicry of happiness and
sadness in PD patients and that this impairment has
behavioural consequences.
Argaud et al. [30] also recruited healthy controls and PD
patients with mild PD (mean Hoehn and Yahr stage � 1.7)
and an absence of depression, dementia, drug abuse, or other
psychiatric illnesses. Patients were all taking dopaminergic
replacement therapy and underwent testing on their usual
dosage of medication. Patients and controls had muscle
activity recorded via EMG at the left zygomaticus major,
orbicularis oculi, and corrugator supercilii muscles while
observing dynamic stimuli depicting happy, angry, and
neutral emotions. After each avatar display, participants
were asked to rate the degree of depicted emotional expression along seven visual analogue scales (VAS) corresponding to joy, sadness, fear, anger, disgust, surprise, and
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neutral. Several signiﬁcant diﬀerences in emotion recognition and facial mimicry were observed. First, the PD patients
had signiﬁcantly lower accuracy scores for the VAS ratings
compared to controls, particularly for happy and neutral
expressions but not angry. Second, the PD patients demonstrated reduced corrugator supercilii mimicry to angry
expressions compared to controls, and almost nonexistent
zygomaticus major and orbicularis oculi mimicry toward
happy faces. These results support those obtained by Livingstone et al. [31], suggesting that PD patients demonstrate
reduced facial mimicry compared to controls, with a particular deﬁcit in happy mimicry, which is related to problems
identifying emotions.
Once again, based on the evidence synthesized in the
present review, it is surprising that very few studies have
investigated facial mimicry in PD patients. Many questions still remain unanswered, including whether dopaminergic treatment has an eﬀect on facial mimicry, how
the deﬁcit is aﬀected by the time course of the disease, and
which brain structures underlie the reduction in mimicry.
It is also interesting to note that both of these facial
mimicry studies found deﬁcits with happy expressions
speciﬁcally, while performance with angry expressions was
relatively spared. This is in contrast with the majority of
emotion recognition studies in PD patients, which generally ﬁnds that happy face recognition remains high in PD
patients [6, 8].
4.4. Compensatory Strategies. Studies of other clinical
populations with facial movement dysfunction have shown
a preserved ability to recognize emotions despite the inability to mimic. For example, a small sample of patients
with Möebius syndrome (congenital facial paralysis)
showed no impairment on a recognition test of the six basic
emotions [74]. Interestingly, this preserved ability might be
due to the development of compensatory mechanisms
which facilitate emotion recognition in the absence of
mimicry. Indeed, Goldman and Sripada [20] describe an
alternate emotion simulation route that bypasses motor
activation, going from the observation of an expression
straight to neural representation and recognition of the
emotion. Amazingly, there might be evidence that some PD
patients are able to form compensatory mechanisms
similar to those with Möebius syndrome in order to preserve emotion recognition when facial mimicry is reduced.
In other words, PD patients might be able to become more
reliant on some alternative route of emotion recognition.
Wabnegger and colleagues [75] conducted an fMRI study
comparing PD patients and healthy controls during negative emotion recognition (i.e., anger, fear, and sadness).
The authors observed no diﬀerences between these two
groups in their ability to recognize emotions or in the
activated areas of the brain, except for greater activation of
the somatosensory cortex in PD patients. Furthermore, the
level of somatosensory cortex activation was positively
correlated with emotion recognition ability. Similarly,
Anders and colleagues [76] found increased activity in
the right ventrolateral premotor cortex in asymptomatic
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Parkin mutation carriers compared to controls, which was
positively correlated with emotion recognition ability.
Again, this may demonstrate a compensatory mechanism
involving movement preparation and sensory feedback
signals which facilitates recognition when mimicry pathways are disrupted.

5. Conclusions
In this review, we have presented an argument suggesting that
emotion recognition impairment in PD patients might be
related to deﬁcits in emotion expressivity. This could be due to
hypomimia (i.e., hypokinesia and bradykinesia of facial expressions), cognitive impairment related to basal ganglia
dysfunction, or possible dysfunction of the mirror neuron
system. In sum, it is likely that PD patients demonstrate
reduced facial mimicry which contributes to emotion recognition impairment. However, only two studies to date have
examined facial mimicry abilities in PD patients, both of
which have shown evidence of a deﬁcit in facial mimicry.
An alternative explanation to the evidence presented in
this review could argue that PD patients’ reduction in facial
mimicry is due to an initial inability to recognize the
emotion to be mimicked, not the other way around.
However, theorists hold that facial mimicry occurs prior to
the recognition of an emotion for two main reasons, outlined by Goldman and Sripada [20]. First, facial mimicry is
known to be a part of a more general mirroring system,
which includes mimicry of more distal parts of the body
(e.g., mimicking another person’s leg crossing) which are not
dependent on emotional processes. Although no studies
have directly studied bodily mirroring behaviour in the PD
population, the symptoms of bradykinesia and hypokinesia
and evidence of a dysfunctional mirroring system in PD
patients would suggest that mirroring behaviour is reduced
overall in PD patients. Second, when facial muscles are
manipulated into an expression without association with an
emotion (e.g., when asked to say “cheese” to produce
a smile), evidence shows that aﬀective changes still ensue
and that recognition of congruent emotions improves [77].
Embodied simulation theory strongly holds that facial
mimicry precedes and aids in the recognition of emotions.
Again, if mimicry is indeed reduced in PD patients, it is
highly likely that this contributes to the symptom of impaired emotional recognition. Although only two studies
have investigated facial mimicry in PD patients, both
demonstrated a deﬁcit in mimicry (particularly for happiness) which was coupled with behavioural consequences.
There is a desperate need for more research into this area to
determine the mechanisms behind mimicry and recognition
deﬁcits in PD patients. This enhanced understanding could
lead to improved emotion processing and quality of life in
PD patients.
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